AI In Clinical Development
Speed without shortcuts: AI in clinical development
Our vision is to develop AI solutions that enable faster delivery of new medicines to patients.
AI in Clinical Development is at the core of Parexel’s approach to accelerating first-time quality and milestone delivery through our strategic operating model, Parexel Precision Pathway. We’re committed to the development of innovative, high-value use cases for AI in clinical trials. AI empowers our people at critical decision points and our AI investments prioritize process optimizations that:
- Simplify complex tasks to accelerate timelines
- Apply insights with agility to enable better decision-making
- Enhance data handling to drive first time quality through content generation and workflow automation.
Parexel has implemented AI and other advanced technologies to accelerate clinical trial execution, while always maintaining the human in the loop.
Key use cases for AI in clinical development
Study design and planning
- Study design optimization
- Precise site selection
- Patient identification
Study start-up and execution
- Achieve increased speed and quality of statistical programming
- Site contracting, grant management and payment solutions
- Monitoring visit preparation and report generation
Clinical trial data and analysis
- SDTM conversion and automated data workflows optimized with AI
Regulatory and safety
- Accelerate speed of delivery in medical writing
- Improve efficiency and effectiveness of regulatory affairs functions via machine learning and generative AI tools
- Streamline adverse event case processing for speed and higher quality
Post approval activities
- Enhance evidence generation for market access and HEOR strategy with predictive modeling tools
Operational efficiency with AI-driven automation
Nearly 50 robotic process automation (RPA – aka bots) solutions have been deployed in workflows across Parexel. These bots drive efficiency, enable faster timelines, and deliver first time quality.
The vision behind our AI-enabled platform
Meaningful change always starts with a vision. We envisioned an AI-enabled platform that automates data management processes end to end—from data input, through analysis, to regulatory submission.
Partnering with Palantir to build an AI ecosystem
Today we’re building the end-to-end AI ecosystem with Palantir Technologies Inc, a software company that builds platforms to power real-time, AI-driven decision-making.
Transforming trial execution with AI-powered workflows
Palantir’s core product, AIP, is used to create a central operating system with tools that support AI automation combined with human-in-the-loop decision making. Parexel is leveraging AIP to transform trial execution from siloed, semi-manual tasks into integrated, AI-powered workflows driven by scalable insights and predictive intelligence.
Ethically leveraging AI in clinical trials
The six principles set out below describe how Parexel conceives, develops, deploys, and monitors AI applications intended for use in clinical development and throughout our business. By adhering to these tenets, we ensure that Parexel respects the rights of all relevant stakeholders, mitigates or eliminates known risks, and uses AI applications safely.
- Thoughtful design and deployment
- Accountability and senior-level governance
- Human oversight and control
- Transparent AI
- Regulatory conformance and legal compliance
- Security and privacy
Our journey with AI and HyperAutomation is just beginning. We look forward to sharing how we’re using AI to help manage the increasing complexity of clinical development, including opportunities to expedite development timelines so life-changing products reach patients more quickly.